# Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

Study · id `cardio:ct-nct03241459` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03241459](<https://clinicaltrials.gov/study/NCT03241459>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03241459

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 446 participants.

## Technical summary

Registry record NCT03241459. Randomized; single masking; primary purpose treatment. Start 2017-10-23 (actual); primary completion 2020-09-15 (actual). Results posted on 2024-04-09.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 446 participants (enrolled count; ClinicalTrials.gov record NCT03241459, source copy `cardio:ctgov-nct03241459-2025-03-25`, retrieved 2026-10-31)
- Started: 2017-10-23 (actual) (ClinicalTrials.gov record NCT03241459, source copy `cardio:ctgov-nct03241459-2025-03-25`, retrieved 2026-10-31)
- Primary completion: 2020-09-15 (actual) (ClinicalTrials.gov record NCT03241459, source copy `cardio:ctgov-nct03241459-2025-03-25`, retrieved 2026-10-31)
- Completion: 2024-09-17 (actual) (ClinicalTrials.gov record NCT03241459, source copy `cardio:ctgov-nct03241459-2025-03-25`, retrieved 2026-10-31)
- Results first posted: 2024-04-09 (ClinicalTrials.gov record NCT03241459, source copy `cardio:ctgov-nct03241459-2025-03-25`, retrieved 2026-10-31)
- Countries: United States; Australia; Austria; Belgium; Czechia; Germany; Italy; Latvia; New Zealand (ClinicalTrials.gov record NCT03241459, source copy `cardio:ctgov-nct03241459-2025-03-25`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03241459-2025-03-25`, retrieved 2026-10-31)

## The registry's words

- Brief title: Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
- Acronym: TRANSCEND
- Condition: Peripheral Arterial Disease
- Condition: Peripheral Vascular Disease
- Condition: Artery Disease, Peripheral
- Condition: Femoropopliteal Artery Occlusion
- Intervention (Device): Surmodics SurVeil DCB
- Intervention (Device): Medtronic IN.PACT Admiral DCB
- Lead sponsor: SurModics, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Editor's Choice - Results of SurVeil Versus IN.PACT Admiral Paclitaxel Coated Balloons in Femoropopliteal Arteries: 24 Month Outcomes of the Randomised TRANSCEND Study (`cardio:pubmed-39615582`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: d61e55e39a082b380fd497ccf3a2582eb12ec5dd2cda2d32cb17e82408ca45d4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
